97 related articles for article (PubMed ID: 8967550)
1. [The efficacy and safety of nafarelin in treating genital endometriosis].
Nikolov A; Karag'ozov I; Novachkov V
Akush Ginekol (Sofiia); 1996; 35(1-2):63-6. PubMed ID: 8967550
[TBL] [Abstract][Full Text] [Related]
2. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
[TBL] [Abstract][Full Text] [Related]
3. Treatment with nafarelin for endometriosis in young women. Efficacy, safety and lipid metabolism. Niigata Nafarelin Study Group.
Kurabayashi T; Takakuwa K; Tanaka K
J Reprod Med; 2000 Jun; 45(6):454-60. PubMed ID: 10900577
[TBL] [Abstract][Full Text] [Related]
4. [Current aspects on the treatment of endometriosis].
Bergqvist A; Bergquist C; Nordenskjöld F
Lakartidningen; 2000 Feb; 97(8):818-22, 824. PubMed ID: 10741021
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis.
Bergqvist A;
Gynecol Endocrinol; 2000 Dec; 14(6):425-32. PubMed ID: 11228063
[TBL] [Abstract][Full Text] [Related]
6. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy ("draw-back" therapy).
Tahara M; Matsuoka T; Yokoi T; Tasaka K; Kurachi H; Murata Y
Fertil Steril; 2000 Apr; 73(4):799-804. PubMed ID: 10731543
[TBL] [Abstract][Full Text] [Related]
7. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.
Agarwal SK; Hamrang C; Henzl MR; Judd HL
J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932
[TBL] [Abstract][Full Text] [Related]
8. Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density.
Hornstein MD; Yuzpe AA; Burry K; Buttram VC; Heinrichs LR; Soderstrom RM; Steinberger E; Lin JS
Fertil Steril; 1997 Jun; 67(6):1013-8. PubMed ID: 9176437
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbation of chronic maxillary sinusitis during therapy with nafarelin nasal spray.
Heinig J; Coenen-Worch V; Cirkel U
Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):266-7. PubMed ID: 11788185
[TBL] [Abstract][Full Text] [Related]
10. [Results of treating endometriosis with nafarelin].
Marianowski L; Kamiński P
Wiad Lek; 1994 Aug; 47(15-16):595-7. PubMed ID: 7716957
[TBL] [Abstract][Full Text] [Related]
11. Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures.
Zhao SZ; Kellerman LA; Francisco CA; Wong JM
J Reprod Med; 1999 Dec; 44(12):1000-6. PubMed ID: 10649809
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.
Bergqvist A; Jacobson J; Harris S
Gynecol Endocrinol; 1997 Jun; 11(3):187-94. PubMed ID: 9209899
[TBL] [Abstract][Full Text] [Related]
13. [Using GnRH-agonists (Zoladex) in the treatment of genital endometriosis].
Nikolov A; Tiufekchieva E; Novachkov V; Karag'ozov I
Akush Ginekol (Sofiia); 2006; 45(4):13-20. PubMed ID: 16889194
[TBL] [Abstract][Full Text] [Related]
14. Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration.
Taga M; Minaguchi H
Acta Obstet Gynecol Scand; 1996 Feb; 75(2):162-5. PubMed ID: 8604604
[TBL] [Abstract][Full Text] [Related]
15. Changes in quality of life after hormonal treatment of endometriosis.
Bergqvist A; Theorell T
Acta Obstet Gynecol Scand; 2001 Jul; 80(7):628-37. PubMed ID: 11437721
[TBL] [Abstract][Full Text] [Related]
16. Nafarelin in the treatment of endometriosis. Dose management.
Hull ME; Barbieri RL
Gynecol Obstet Invest; 1994; 37(4):263-4. PubMed ID: 8050732
[TBL] [Abstract][Full Text] [Related]
17. Treatment of endometriosis with the GnRH agonist nafarelin acetate.
Jacobs LA; Field CS; Thie JL; Coulam CB
Int J Fertil; 1991; 36(1):30-5. PubMed ID: 1672673
[TBL] [Abstract][Full Text] [Related]
18. [Conservative treatment of interstitial ectopic pregnancy and endometriosis with laparoscopic methotrexate and potassium chloride and complementary management with nasal nafarelin. Report of a case and review of the literature].
Sánchez Contreras J; Hernández Vivar LE; Villalobos Cid MA; Risco Cortés RJ
Ginecol Obstet Mex; 2000 Jan; 68():35-8. PubMed ID: 10774100
[TBL] [Abstract][Full Text] [Related]
19. Effect of insuflated Nafarelin (D-Nal-6-GnRH) upon uterine leiomyomata.
Ayala AR; Meza E; Cervera Aguilar R; Hernández Marín I
Arch Med Res; 1995; 26 Spec No():S23-6. PubMed ID: 8845654
[TBL] [Abstract][Full Text] [Related]
20. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?
Agarwal SK
J Reprod Med; 2002 Jul; 47(7):530-4. PubMed ID: 12170527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
